Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience. (2024). Dermatology Practical & Conceptual, 14(3), e2024179. https://doi.org/10.5826/dpc.1403a179